INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Grant or awardVerified data

Tardiff Daniel reported CAMP

Chief Scientific Officer · Camp4 Therapeutics Corp · Camp4 Therapeutics Corp — Stock Option (Right to Buy)

Side
A
Value
—
Shares
145.5K
Price
—
Executed
Dec 11, 2025
Disclosed
Dec 22, 2025
Disclosure timeline11 days from execution to publication · legal deadline 2 business days
Dec 11 executedDec 22, 2025 disclosed

CAMP · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
19/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing+10 / 15

    Disclosed 7 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CAMP

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    GK
    Gold KellyChief Financial Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    215.0K sh
    		Apr 1, 2026Apr 3, 2026
    traded Apr 1, 2026
    		+2dSEC FORM 4

    Evidence

    9
    TD
    Tardiff DanielChief Scientific Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    170.0K sh
    		Apr 1, 2026Apr 3, 2026
    traded Apr 1, 2026
    		+2dSEC FORM 4

    Evidence

    19
    GK
    Gold KellyChief Financial Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    190.0K sh
    		Dec 11, 2025Dec 22, 2025
    traded Dec 11, 2025
    		+11dSEC FORM 4

    Evidence

    19
    MJ
    Mandel-Brehm JoshDirector, Chief Executive Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    425.0K sh
    		Dec 11, 2025Dec 22, 2025
    traded Dec 11, 2025
    		+11dSEC FORM 4

    Evidence

    19
    MY
    Maricich YuriChief Medical Officer
    CAMPCamp4 Therapeutics Corp
    Grant or award
    		A—
    190.0K sh
    		Dec 11, 2025Dec 22, 2025
    traded Dec 11, 2025
    		+11dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002089301-25-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 11, 2025
    Published
    Dec 22, 2025
    Ingested by INSIDER
    Nov 5, 04:26 UTC
    Last re-read
    Nov 5, 04:26 UTC

    Extracted facts

    Filer
    Tardiff Daniel
    Role
    Chief Scientific Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Camp4 Therapeutics Corp — Stock Option (Right to Buy)
    Ticker
    CAMP
    Shares
    145.5K
    Price per share
    $0
    Execution date (reported)
    Dec 11, 2025
    Owned after transaction
    145.5K shares
    Days from execution to publication
    11

    What this establishes

    Tardiff Daniel filed this Form 4 reporting a grant or award of CAMP on Dec 11, 2025. It became public on Dec 22, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Scientific Officer
    Tardiff Danielcik:0002089301
    Issuer
    Camp4 Therapeutics Corpcik:0001736730

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.